News | August 25, 2011

MedQuist Holdings Inc. Completes Merger with M*Modal

August 25, 2011 — MedQuist Holdings Inc., provider of integrated clinical documentation solutions for the United States healthcare system, announced it has closed on the acquisition of M*Modal. The closing price included $48.4 million in cash and the issuance of 4.1 million shares of MedQuist Holdings common stock paid at closing. The company received notification of early termination of the mandatory, pre-merger waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976 on Aug. 15.

The two companies are moving aggressively with integration plans, including organizational structure and product strategies.

MedQuist has projected the acquisition of M*Modal, which was not included in the company's recent guidance for fiscal 2011, will be modestly accretive to adjusted net income per fully diluted share in the fourth quarter of 2011. The acquisition will also increase the company's annualized adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) run-rate by approximately $20 million by year-end 2012.

MedQuist will also make $28.8 million in installments paid in cash over the next three years to M*Modal. The company funded the cash component of the purchase price from available cash.

Additionally, MedQuist expects to incur fees and expenses, including additional restructuring and integration costs associated with this transaction, of approximately $13 million over the next 12 months. The founders and senior executives of M*Modal, Michael Finke, Detlef Koll and Juergen Fritsch will remain deeply involved in the company on a go-forward basis.

In connection with and on the closing date of the merger, MedQuist granted inducement awards of 195,894 restricted shares of common stock to Michael Finke, 117,536 restricted shares of common stock to Detlef Koll and 78,358 restricted shares of common stock to Juergen Fritsch.  

All of these shares will vest on the third anniversary of their grant date so long as they remain in continued service to the company. The restricted shares will become fully vested upon a change in control of the company or their deaths, or if their service terminates without cause due to disability or due to resignation with good reason, so long as they timely execute a release of claims. The shares were granted to Finke, Koll and Fritsch as "inducement awards" and therefore, consistent with applicable NASDAQ rules, did not reduce the shares reserved for issuance under MedQuist’s stockholder approved equity plans.

MedQuist also granted up to an aggregate of 391,782 restricted shares of the company's common stock to 89 M*Modal employees who agreed to stay on at MedQuist or a subsidiary. 

For each such employee, their restricted shares will vest proportionally over a three-year period based on continued service, subject to full acceleration upon termination without cause or resignation with good reason. The shares were granted "inducement awards" and therefore, consistent with applicable NASDAQ rules, did not reduce the shares reserved for issuance under the company's stockholder approved equity plans.

For more information: www.medquist.com

Related Content

Fujifilm to Host Pediatric Imaging Best Practices Symposium at AHRA 2018
News | Pediatric Imaging | July 18, 2018
Fujifilm Medical Systems U.S.A. Inc. announced that it will offer educational opportunities and exhibit its latest...
Sponsored Content | Case Study | PACS | July 09, 2018
One of the Northeast’s major teaching hospitals is an international leader in virtually every area of medicine. It has...
Sponsored Content | Whitepapers | PACS | July 09, 2018
The move toward value-based reimbursement (VBR) models is putting pressure on healthcare organizations to modernize...
Wake Radiology Launches First Installation of EnvoyAI Platform
News | Artificial Intelligence | June 13, 2018
Artificial intelligence (AI) platform provider EnvoyAI recently completed their first successful customer installation...
PACS and the Road to Reconstruction
Feature | PACS | June 05, 2018 | By Dave Whitney and Jef Williams
The PACS — picture archiving and communication systems — have been in existence for more than 45 years. One of the...
Intelerad Introduces InteleOne Maestro Enterprise Workflow Orchestration Solution
Technology | PACS Accessories | May 31, 2018
Intelerad Medical Systems announced the release of InteleOne Maestro, its new enterprise imaging workflow orchestration...
Konica Minolta Releases New Turn-Around-Time Feature for Exa Workflow
Technology | PACS | May 30, 2018
Konica Minolta Healthcare Americas Inc. will introduce a new worklist feature, Turn-Around-Time (TAT), for its Exa...
Illuminate and Medexprim Partner to Enhance PACS Data Mining
News | PACS | May 30, 2018
U.S.-based Softek Illuminate and the entrepreneurial French firm Medexprim will be combining, distributing and...
Intelerad Launches AI Initiative for Imaging Workflow Intelligence and Analytics
News | Artificial Intelligence | May 29, 2018
Intelerad Medical Systems announced the launch of its artificial intelligence (AI) initiative along with the expansion...
Australia's Largest Public Health System Selects Sectra for Enterprise Imaging IT Solution
News | PACS | May 24, 2018
Australia’s NSW Health signed a Proof of Concept agreement naming Sectra as the preferred vendor for a large enterprise...
Overlay Init